Network structures from poly(β-amino ester) (PAE) were synthesized for applying as drug delivery matrix via a simplified addition polymerization method. It can hold an active organic compound (drug) that has an effect as antitumor activity in order to control its release. PAE was prepared from piperazine and 1,4-butandiol diacrylate with different molar ratios. The active compound was mixed with the prepared polymer while warming for 15 minutes to obtain the capsule product. The resulting polymer structures and the surface morphology of the PAE capsules before and after encapsulation with the active drug were characterized by FT-IR and SEM, respectively. Swelling and degradation behavior of PAE were studied. The characterization showed that, the obtained network structure of PAE depends on the molar ratio between the reactants. The optimum ratio of the reactants was found to be 1:1. Therefore, stable and white product as well as good holding capability for drug produced. The SEM studies illustrate good dispersion and holding properties of the drug into the network structure of the prepared polymer. In vitro, the release results of the drug from the PAE capsules indicated that the capsules were able to give sustained release of drug in DMF up to 10 days at 25˚C.
Introduction
Many therapeutic anticancer drugs, while pharmacologically effective in cancer treatment, are limited in their clinical applications by serious toxicities. The development of anticancer drug carriers can improve therapeutic efficacy and reduce unwanted side effects [1] . Cationic copolymers have been developed based on poly(amino urethan) and poly(amido-amine) [2, 3] .
Poly(β-amino ester) (PAE) is a cationic polymer which is easily synthesized by addition polymerization and known to be readily biodegradable and of low cytotoxicity [4] . PAE acts as a hydrophilic block because of the ionization of tertiary amine at a relatively low pH and becomes a hydrophobic block because of deionization of tertiary amine at a higher pH [5] . PAE has been widely investigated for gene delivery [6] and cancer cytoplasmic drug release [7] .
The present work aims to synthesize and characterize network structure of poly(β-amino ester) applying as carrier for an active organic compound (antitumor drug) and fabricate into capsule form, also, to evaluate the efficiency of the prepared polymer holding drug for control release drug through the release rate of the active compound.
Materials and Methods

Materials
Piperazine and 1,4-butanediol diacrylate were purchased from Sigma-Aldrich. N-hexane, dimethyl formamide (DMF), dimethyl sulfoxide (DMSO), dichloro methane (DCM), ethyl acetate (EtOAc) and tetrahydrofuran (THF) were obtained from Aldrich. 7-(2-methoxyphenyl)-3-methyl-5-thioxo-5,6-dihydro[1,2,4]-triazolo [4,3-c] pyrimidine-8-carbonitrile (MTPC) which has been prepared and evaluated as anticancer bioactive drug [8] . It has molecular formula as follows.
three neck flask containing reflux condenser and thermometer at 50˚C for 48 hours. So, the 1,4-butandiol diacrylate solution was introduced into the flask and the piperazine solution was added dropwise to the acrylate solution. Different mol ratios of the reactant were used as indicated (1:1), (2.3:1) and (1:2.3). After the reaction was completed, the poly β-amino ester was obtained through precipitation in n-hexan [9] .
Swelling Response of Poly(β-Amino Ester)
The swelling properties of the resulting polymer were evaluated using dimethyl sulfoxide (DMSO), dichloro methane (DCM) and ethyl acetate (EtOAc) at room temperature. The initial mass of the polymer capsules were recorded (W i ), and then, the capsules were placed in the corresponding solvents at room temperature. The capsules were removed from the solvents at a given time, and their masses were recorded in swollen state (W s ). The same solvents were used throughout the swelling studies [10] . The dynamic weight change of the polymer with respect to time was calculated by the following equation:
 
Weight change % 100
where W s and W i are the weight of the polymer in the swollen state and the initial weight of the polymer, respectively.
In Vitro Degradation of PAE
The in vitro degradation of the PAE hydrogel was examined using the mass loss method. Briefly, 4 mL vials contained 100 mg of PAE at pH 7.4 were incubated at 37˚C in 15 min to form a gel. Subsequently, 3 mL of phosphate-buffered saline (PBS, pH 7.4) was added, and the sample vials were incubated at 37˚C. The PBS in the vials was replaced with fresh PBS every day. At a predetermined time, the samples were collected, freeze-dried and the residue weight checked. The remaining weight of the degraded gels was calculated from the ratio of lyophilized degraded gels to the initial gels [11] . The experiments were performed in triplicate.
Drug Encapsulated Polymeric Capsules
The polymeric latex (1 g) was mixed with (0.1 g) of the active prepared drug (organic compound which had promising effect as antitumor) [8] . The drug polymer capsules were left to equilibrate for 24 hours at room temperature.
Determination of the Drug Encapsulation Efficiency
The encapsulation efficiency (EE) was measured after extracting the drug from the prepared polymeric capsules [12] . 100 mg of MTPC-loaded polymeric capsules were subjected to disperse in 100 mL DMF and stirred for 30 min at 37˚C to ensure the complete extraction of the drug. The mixture was stirred magnetically at 1000 rpm for 4 h. The mixture solutions increased to 250 mL volumes with DMF. After centrifuging at 4000 rpm for 30 min, these solutions were diluted and analyzed by a UV-Vis spectrophotometer at 360 nm. All experiments were done in triplicate. The EE of drug is calculated and expressed as the following equation:
  Practical drug loading EE % 100 Theoretical drug loading   .
Drug Release from Polymeric Capsules
In a typical procedure to determine the in vitro release of the drug from the polymeric capsules, drug-loaded capsules prepared were immersed in 10 mL DMF at 37˚C with horizontal shaking. At timed intervals, 1 mL of the medium was withdrawn and the same volume of fresh DMF was added to keep the total volume constant. The drug released into the fluid was determined from the measurement of absorbance at 360 nm analyzed by a UV-Vis spectrophotometer according to the standard curve and expressed as follows:
where released drug was calculated from the drug concentration (mol/L) measured in the total solution volume and total drug was the amount loaded in each capsule. All experiments were done in triplicate.
Characterization
The characterization of the prepared polymer was carried out according to the following techniques: 1) FT-IR spectra were recorded on a FT-IR spectroscopy (Nicolet 670, range from 4000 -400 cm −1 , USA) using KBr pellets.
2) Surface morphology was visualized by scanning electron microscopy (JXA-840A Electron probe microanalyzer, JEOL, Japan) using an accelerating voltage of 30 KV after coating with gold film using S150A Sputter Coater (Edwards, England).
The drug loading and release studies were measured using double-beam Spectrophotometer (Shimadzu UV-2401 PC, Japan).
Results and Discussions
Poly(β-Amino Ester) Synthesis and Characterization
This section focused on the synthesis and characterization of poly(β-amino ester). The addition polymerization process for Piperazine and 1,4-butanediol diacrylate via low temperature resulted in a complex-structured of PAE Copyright © 2013 SciRes. JEAS F. M. HELALY, M. S. HASHEM 67 as described in Scheme 1. Different molar ratios of the reactants were used to give the highlight on the suitable controlling product that gives optimum specific properties for use as polymer carrier drugs. Table 1 summarizes the physical properties of the resulted products of the polymer forms of PAE according to the monomer ratios. It is shown from the visual inspection that, the color of the products changed from pale yellow to yellow and the state of the polymer product changed from gel to brittle solid based on the molar ratio of the reactants. So, it is able to control the properties and molecular weight of the prepared polymer through change molar ratio of the reactants. Therefore, it is necessary for the polymer to have specific properties to ease the holding of the investigated active compound and consequently, useful for applying as drug delivery system for increasing the ability to release the active ingredient for long period of time.
The prepared polymer was characterized using FT-IR and SEM studies. Figure 1 indicated the IR spectra of the prepared Poly(β-amino ester). It is shown that, the characteristic peaks for the functional groups are found at 1259 cm −1 for piperazine group, 3445 cm −1 for OH group and 1637 cm −1 for acrylate group. These results confirmed the presence of PAE.
FT-IR Characterization
at 50°C for 48 h Scheme 1. The reactant materials, conditions and the produced product of PAE. 
SEM Characterization
It is interesting to characterize the surface texture of the investigated poly(β-amino ester) before and after carrying the drug to illustrate what happens to the distribution and spreading of the drug through the surface of the test specimen. Scanning electron microscope is a valuable technique for this study. Figure 2 illustrates the micrograph of the surface texture of the prepared products. Figure 2(a) shows a good homogeneity for the structure texture, no grooves as blistering on the surface of the investigated polymer before carried drug. After carrying the drug, the micrograph in Figure 2(b) shows good dispersion and penetration of the drug through the surface texture of the polymer.
Swelling Response of PAE
The swelling behavior is a very important property for drug delivery system because it has a great influence on the drug release behavior [13] . The swelling study of PAE polymer capsules was conducted in three different solvents: DMSO, DCM and EtOAc at room temperature in order to study the polymer solvent interaction. It has been observed from Figure 3 that for all the systems in DCM and EtOAc the maximum swelling is achieved in approximately 2 h. However, in case of DMSO as solvent, the maximum swelling was observed in approximately 6 h. This dependence of the extent of swelling on the polymer/solvent system could be explained by polymer solvent interaction parameter, which is an indicator of polymer miscibility in the solvent. These results are confirmed with that obtained by Biswal et al. [10] .
In Vitro Degradation of PAE
The degradability of the PAE polymer capsules was monitored by examining the weight loss of capsules according to the incubation time in PBS (pH 7.4) at 37˚C, as shown in Figure 4 . The PAE polymer showed relatively fast degradation in vitro, with 60% and 40% weight remaining after 10 and 14 days, respectively. The results of biodegradation studies in PBS (pH 7.4) at 37˚C were consistent with a polymer that underwent hydrolytic surface degradation as a function of time. The faster degradation profile, as compared to other synthetic polyesters, was due to the ease of surface hydrolysis by water molecules [14] . MTPC, an anticancer drug, from this polymer. The release rate of MTPC from PAE was evaluated spectrophotometerically at 360 nm within the first 48h as shown in Figure 5 (a). It was found that PAE polymer released the anticancer drug in a slow manner. Furthermore, the release profiles showed that MTPC had undergone controlled release from PAE polymer for more than 10 days, as shown in Figure 5 (b).
Conclusion
Network structure of poly(β-amino ester) was synthesized from piperazine and 1,4-butanediol diacrylate by Michael addition polymerization. The prepared polymer carried drug is characterized by FT-IR and SEM. The release of the drug was extended to over 10 days in DMF at 25˚C.
